Cardiotoxicity of Trastuzumab Treatment in African American Women and Older Women in the Non Trial Setting.
Jessica N. Snider(University of Tennessee Health Science Center), Jasgit C. Sachdev(HonorHealth), Lori Kronish, Gregory A. Phelps(St. Jude Children's Research Hospital), Mohammad Jahanzeb(21st Century Oncology (United States)), C. Paba(University of Tennessee at Knoxville), Soha Ahmed(University of Tennessee at Knoxville), C S Verrier(University of Tennessee at Knoxville)
Cited by 2
Related Papers
AKT in cancer: new molecular insights and advances in drug development
|British Journal of Clinical Pharmacology|2016|267
Effect of Capivasertib in Patients With an <i>AKT1 E17K</i>-Mutated Tumor
|JAMA Oncology|2020|106
The Structural and Functional Basis for Recurring Sulfa Drug Resistance Mutations in Staphylococcus aureus Dihydropteroate Synthase
|Frontiers in Microbiology|2018|94
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody–Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors
|Clinical Cancer Research|2021|81
Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial).
|Journal of Clinical Oncology|2020|68